Please assess the completion status of the following clinical trial:

Trial Title: PReservation Study of Ovarian Function And Hemostasis, and Its Safety of Surgiguard@ During Laparoscopic Ovarian Cystectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Female, 18 years ≤ Ages \<45 years~* laparoscopic unilateral ovarian cystectomy scheduled patients with benign unilateral ovarian cyst confirmed by ultrasonography~* women with regular menstruation~* women with regular menstruation cycle from 21 days to 45 days~* Proper state for laparoscopic operation (American society of Anesthesiologists Physical Status classification 1 or 2)~* Patients who signed and approved informed consent~Exclusion Criteria:~* Patients without ovarian cyst~* Patients with malignant female genital disease~* Patients with bilateral ovarian cysts~* Age ≥ 45~* Pregnancy or lactating women~* Serum AMH\<0.05 ng/ml~* Patients with endocrine disease such as thyroid abnormality, hyperprolactinemia, cushing disease, etc~* Patients with hormone replacement therapy during 3 months~* Patients who is considered to be difficult to perform the clinical trial when researchers judge

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- SurgiGuard (Type: ACTIVE_COMPARATOR): Surgiguard Non-woven Drug : SurgiGuard Non-woven 6g during surgery
- Bipolar electrocauterization (Type: NO_INTERVENTION): Bipolar electrocauterization during surgery Drug(-)

Based on this trial design, predict the completion outcome and termination type (if applicable).